These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36470173)
1. Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients. Ruiz-Idiago J; Pomarol-Clotet E; Salvador R Parkinsonism Relat Disord; 2023 Jan; 106():105228. PubMed ID: 36470173 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease. Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966 [TBL] [Abstract][Full Text] [Related]
3. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease. Julayanont P; Heilman KM; McFarland NR Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295 [TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB; J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898 [TBL] [Abstract][Full Text] [Related]
5. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period. van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661 [TBL] [Abstract][Full Text] [Related]
6. Assessing Mental Health Difficulties of Persons With Huntington's Disease: Does Informant Presence Make a Difference? Gunn S; Maltby J; Dale M J Neuropsychiatry Clin Neurosci; 2020; 32(3):244-251. PubMed ID: 32102601 [TBL] [Abstract][Full Text] [Related]
7. Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD dataset. Harris KL; Mason SL; Barker RA J Neurol; 2022 Jul; 269(7):3501-3510. PubMed ID: 35165768 [TBL] [Abstract][Full Text] [Related]
8. Negative symptoms in Huntington's disease. Soliveri P; Paridi D; Del Sorbo F; Tramacere I; Girotti F Neurol Sci; 2022 Jun; 43(6):3695-3701. PubMed ID: 35067828 [TBL] [Abstract][Full Text] [Related]
9. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease. Saiz-Rodríguez M; Gil-Polo C; Diez-Fairen M; Martinez-Horta SI; Sampedro Santalo F; Calvo S; Alonso-García E; Riñones-Mena E; Aguado L; Mariscal N; Muñoz-Siscart I; Piñeiro D; Rivadeneyra J; Cubo E Neurol Sci; 2022 Oct; 43(10):6079-6085. PubMed ID: 35725858 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. Thompson JC; Harris J; Sollom AC; Stopford CL; Howard E; Snowden JS; Craufurd D J Neuropsychiatry Clin Neurosci; 2012; 24(1):53-60. PubMed ID: 22450614 [TBL] [Abstract][Full Text] [Related]
12. Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross-sectional study. Migliore S; D'Aurizio G; Maffi S; Ceccarelli C; Ristori G; Romano S; Castaldo A; Mariotti C; Curcio G; Squitieri F Brain Behav; 2021 Jul; 11(7):e02151. PubMed ID: 34110097 [TBL] [Abstract][Full Text] [Related]
13. Apathy and Impulsivity Co-Occur in Huntington's Disease. Morris LA; Horne KL; Paermentier L; Buchanan CM; MacAskill M; Myall D; Husain M; Roxburgh R; Anderson T; Heron CL Brain Behav; 2024 Oct; 14(10):e70061. PubMed ID: 39344371 [TBL] [Abstract][Full Text] [Related]
14. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study. Jacobs M; Hart EP; van Zwet EW; Bentivoglio AR; Burgunder JM; Craufurd D; Reilmann R; Saft C; Roos RA; J Neurol; 2016 Oct; 263(10):2080-5. PubMed ID: 27435968 [TBL] [Abstract][Full Text] [Related]
16. The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington's Disease from China: A Cross-Sectional Study. Cheng Y; Gu X; Liu K; Yang T; Xiao Y; Jiang Q; Huang J; Lin J; Wei Q; Ou R; Hou Y; Zhang L; Li C; Burgunder JM; Shang H J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615008 [TBL] [Abstract][Full Text] [Related]
17. The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease. Ferreira-Correia A; Krause A; Anderson DG J Huntingtons Dis; 2020; 9(4):325-334. PubMed ID: 33044188 [TBL] [Abstract][Full Text] [Related]
18. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study. Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091 [TBL] [Abstract][Full Text] [Related]
19. Mental health symptoms among those affected by Huntington's disease: A cross-sectional study. Gunn S; Dale M; Ovaska-Stafford N; Maltby J Brain Behav; 2023 Apr; 13(4):e2954. PubMed ID: 36880126 [TBL] [Abstract][Full Text] [Related]
20. Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease. Fritz NE; Boileau NR; Stout JC; Ready R; Perlmutter JS; Paulsen JS; Quaid K; Barton S; McCormack MK; Perlman SL; Carlozzi NE; J Neuropsychiatry Clin Neurosci; 2018; 30(3):194-201. PubMed ID: 29558861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]